A detailed history of Israel Englander (Millennium Management LLC) transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 561,826 shares of RLMD stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
561,826
Previous 64,357 772.98%
Holding current value
$1.57 Million
Previous $193,000 843.01%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.3 - $4.36 $1.14 Million - $2.17 Million
497,469 Added 772.98%
561,826 $1.82 Million
Q2 2024

Aug 14, 2024

SELL
$2.93 - $4.94 $811,882 - $1.37 Million
-277,093 Reduced 81.15%
64,357 $193,000
Q1 2024

May 15, 2024

BUY
$3.1 - $6.8 $441,901 - $969,333
142,549 Added 71.67%
341,450 $1.59 Million
Q4 2023

Feb 14, 2024

SELL
$2.45 - $4.22 $355,431 - $612,212
-145,074 Reduced 42.18%
198,901 $823,000
Q2 2023

Aug 14, 2023

BUY
$2.22 - $3.54 $314,456 - $501,430
141,647 Added 70.01%
343,975 $846,000
Q1 2023

May 15, 2023

SELL
$2.24 - $4.76 $1.93 Million - $4.09 Million
-859,446 Reduced 80.94%
202,328 $457,000
Q4 2022

Feb 14, 2023

BUY
$2.17 - $35.84 $2.26 Million - $37.3 Million
1,042,044 Added 5281.52%
1,061,774 $3.71 Million
Q3 2022

Nov 14, 2022

SELL
$18.3 - $37.02 $1.81 Million - $3.66 Million
-98,780 Reduced 83.35%
19,730 $730,000
Q2 2022

Aug 15, 2022

SELL
$16.5 - $30.34 $2.66 Million - $4.89 Million
-161,079 Reduced 57.61%
118,510 $2.25 Million
Q1 2022

May 16, 2022

SELL
$16.72 - $26.99 $4.59 Million - $7.41 Million
-274,403 Reduced 49.53%
279,589 $7.55 Million
Q4 2021

Feb 14, 2022

BUY
$16.93 - $26.82 $5.07 Million - $8.03 Million
299,412 Added 117.61%
553,992 $12.5 Million
Q3 2021

Nov 15, 2021

BUY
$21.86 - $34.77 $5.21 Million - $8.29 Million
238,351 Added 1468.67%
254,580 $6.67 Million
Q2 2021

Aug 16, 2021

BUY
$29.55 - $39.15 $291,363 - $386,019
9,860 Added 154.81%
16,229 $519,000
Q1 2021

May 17, 2021

SELL
$31.52 - $39.28 $585,042 - $729,076
-18,561 Reduced 74.45%
6,369 $224,000
Q4 2020

Feb 16, 2021

SELL
$29.88 - $39.8 $549,732 - $732,240
-18,398 Reduced 42.46%
24,930 $800,000
Q2 2020

Aug 14, 2020

BUY
$31.59 - $49.98 $154,948 - $245,151
4,905 Added 12.77%
43,328 $1.94 Million
Q1 2020

May 14, 2020

BUY
$23.78 - $50.12 $361,979 - $762,926
15,222 Added 65.61%
38,423 $1.31 Million
Q4 2019

Feb 14, 2020

BUY
$10.1 - $47.18 $234,330 - $1.09 Million
23,201 New
23,201 $905,000

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $80.1M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.